Precision Health Care

We believe Prevention is Better Than Cure.
We only provide the best to our customers.

pWGS

Premium Whole Genome Sequencing Health Management

An all-in-one Premium WGS Health Management solution that provides hereditary cancer screening, chronic disease screening, common genetic disorder among Han Chinese, and pharmacogenomics information to our users, helping them manage their health better with their own gene knowledge.

pWES

Premium Whole Genome Sequencing Health Management

pWES is a cost-effective alternative to pWGS that analyzes only the protein coding area instead of the whole genome. pWES can achieve 80% of results with half of the price compared to pWGS.

pWES+

Premium Whole Genome Sequencing Health Management

pWES+ is a combination of standard WES and lcWGS (Low coverage WGS) that allows us to accurately impute the introns area (non-protein coding area) and avoid missing CNV (Copy number variance) with lower cost compared to standard WGS.

Diseases

Hereditary Cancer

Cardiovascular Disease

Neurological Disease

Metabolic Syndrome

Common Genetic Disorder for Han Chinese

Other diseases

Pharmacogenomics

Traditionally, doctors go through a series of trial and error to find out the most effective treatment, including the right drug and suitable dosage. Pharmacogenomics helps us understand how genes affect a person's response to certain drugs, so the doctors can make more precise prescriptions without traditional trial and errors. 
Anticancer Medication
Immunosuppressive Drug
NSAID
Proton-pump Inhibitor
Antidepressant
Statin Medication
Anticonvulsant

Polygenic Risk Score

Based on our access to the biobanks in Taiwan, we are building the PRS models for Han Chinese population on the following diseases:

CKM

Cancer

Cardio-kidney-metabolic (CKM)

CKM syndrome is a term to describe the interconnection between cardiovascular disease, type 2 diabetes, and chronic kidney disease.

 

  • Cardiovascular disease (CVD), such as Polygenic hypercholesterolemia Hypertrophic cardiomyopathy (HCM), and atrial fibrillation (AF).
  • Chronic kidney disease (CKD) and End- stage kidney disease (ESKD).
  • T2DM and related complications, such as Diabetic retinopathy (DR).

 

Cancer

Breast cancer (BC) and Hepatocellular carcinoma (HCC) are our primary focus. Secondary focus will be Lung cancer (LC), Colorectal cancer (CRC) and Prostate cancer (PC).

Partners

asset 5
asset 4
asset 6
asset 5
asset 4
asset 6
asset 5
asset 4
asset 6

Contact Us

We are looking for partners worldwide to improve public health together!